| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $190.4M | — |
| Cost of Revenue | $2.7M | — |
| R&D Expense | $40.6M | -48.3% |
| SG&A Expense | $132.1M | +24.8% |
| Operating Income | $9.4M | +105.0% |
| Interest Expense | $5.5M | +2270.6% |
| Pre-tax Income | $20.9M | +111.9% |
| Income Tax | $0 | — |
| Net Income | $20.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.1M | -20.3% |
| Short-term Investments | $235.4M | +15.7% |
| Accounts Receivable | $28.2M | — |
| Inventory | $15.0M | — |
| Current Assets | $355.8M | +21.1% |
| Total Assets | $563.8M | +70.4% |
| Current Liabilities | $61.4M | +227.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $46.8M | +167.7% |
| Capital Expenditures | $73K | -66.5% |
| Investing Cash Flow | -$201.8M | +10.6% |
| Financing Cash Flow | $137.2M | -35.6% |
| Free Cash Flow | $46.7M | +167.4% |
| +111.9% |
| EPS (Basic) | $0.40 | +109.1% |
| EPS (Diluted) | $0.39 | +108.9% |
| Long-term Debt |
| $49.9M |
| +0.1% |
| Total Liabilities | $113.7M | +32.4% |
| Stockholders' Equity | $450.1M | +83.6% |